


Company Information
Ask for more detail from the seller
Contact SupplierPalbociclib 125 mg, commonly known by the brand name Ibrance®, is an oral targeted cancer therapy used to treat specific types of advanced or metastatic breast cancer. It is a cyclin-dependent kinase (CDK) 4/6 inhibitor that works by slowing down the growth and division of cancer cells.

